Clinical Trial Update: MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating model-driven precision dosing for ustekinumab and vedolizumab in inflammatory bowel disease, including Crohn's disease and ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)
• Stelara (ustekinumab)

Snippet

Sponsor: Odense University Hospital | Conditions: Inflammatory Bowel Diseases, Crohn Disease | Phase 4 | Status: NOT_YET_RECRUITING